Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

"Introductory to the ESPEN Guidelines on Enteral Nutrition: terminology, definitions and general topics" Clin Nutr (2006) 10.1016/j.clnu.2006.02.007

[2]

"Frailty consensus: a call to action" J Am Med Dir Assoc (2013) 10.1016/j.jamda.2013.03.022

[3]

"Sarcopenia: revised European consensus on definition and diagnosis" Age Ageing (2019) 10.1093/ageing/afy169

[4]

"Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis" Aliment Pharmacol Ther (2020) 10.1111/apt.15571

[5]

"Sarcopenic obesity in cirrhosis—the confluence of 2 prognostic titans" Liver Int (2018) 10.1111/liv.13876

[6]

"Patient knowledge about disease self‐management in cirrhosis" Am J Gastroenterol (2013) 10.1038/ajg.2012.214

[7]

"Patient education and its effect on self‐management in cirrhosis: a pilot study" Eur J Gastroenterol Hepatol (2016) 10.1097/meg.0000000000000579

[8]

"Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real‐life cross‐sectional study" Liver Int (2015) 10.1111/liv.12583

[9]

"Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease" World J Gastroenterol (2020) 10.3748/wjg.v26.i31.4567

[10]

"Folate deficiency in patients seeking treatment of alcohol use disorder" Drug Alcohol Depend (2017) 10.1016/j.drugalcdep.2017.08.039

[11]

"Alcoholism and nutrition: a review of vitamin supplementation and treatment" Curr Opin Clin Nutr Metab Care (2020)

[12]

"Fat‐soluble vitamin levels in patients with primary biliary cirrhosis" Am J Gastroenterol (2001) 10.1111/j.1572-0241.2001.04134.x

[13]

"Serum lipid and fat‐soluble vitamin levels in primary sclerosing cholangitis" J Clin Gastroenterol (1995) 10.1097/00004836-199504000-00011

[14]

"Vitamin D deficiency" N Engl J Med (2007) 10.1056/nejmra070553

[15]

"Prevalence of vitamin D deficiency in chronic liver disease" Dig Dis Sci (2009)

[16]

"Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: a prospective cohort study" PLoS One (2018)

[17]

"Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis" Aliment Pharmacol Ther (2015) 10.1111/apt.13244

[18]

"Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis" Hepatology (1992) 10.1002/hep.1840160326

[19]

"Serum zinc level is associated with frailty in chronic liver diseases" J Clin Med (2020) 10.3390/jcm9051570

[20]

"Serum zinc concentration and sarcopenia: a close linkage in chronic liver diseases" J Clin Med (2019) 10.3390/jcm8030336

[21]

"Zinc and magnesium in liver cirrhosis" Eur J Clin Invest (1994) 10.1111/j.1365-2362.1994.tb00980.x

[22]

"Muscle strength, Na, K‐pumps, magnesium and potassium in patients with alcoholic liver cirrhosis—relation to spironolactone" J Intern Med (2002) 10.1046/j.1365-2796.2002.01008.x

[23]

"Decreased muscle strength and contents of Mg and Na, K‐pumps in chronic alcoholics occur independently of liver cirrhosis" J Intern Med (2003) 10.1046/j.1365-2796.2003.01100.x

[24]

"The role of magnesium in the pathogenesis of bone disease in childhood cholestatic liver disease: a preliminary report" J Pediatr Gastroenterol Nutr (1997)

[25]

"Bile salts and cholestasis" Dig Liver Dis (2010) 10.1016/j.dld.2010.03.015

[26]

"Prevalence of malnutrition and risk of undernutrition in hospitalised children with liver disease" J Nutr Sci (2017)

[27]

"High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation" Liver Transpl (2013) 10.1002/lt.23646

[28]

"Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis" J Clin Invest (1981) 10.1172/jci110240

[29]

"Nature and quantity of fuels consumed in patients with alcoholic cirrhosis" J Clin Invest (1983) 10.1172/jci111142

[30]

"Resting energy expenditure should be measured in patients with cirrhosis, not predicted" Hepatology (1999) 10.1002/hep.510300326

[31]

"Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study" Am J Clin Nutr (2007) 10.1093/ajcn/85.5.1257

[32]

"Are predictive energy expenditure equations accurate in cirrhosis?" Nutrients (2019)

[33]

"Leucine metabolism in stable cirrhosis" Hepatology (1986) 10.1002/hep.1840060412

[34]

"Clearance rate of plasma branched‐chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis" Int Hepatol Commun (1995) 10.1016/0928-4346(94)00159-3

[35]

"Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis" Hepatology (1988) 10.1002/hep.1840080509

[36]

"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver" Hepatology (2014) 10.1002/hep.27210

[37]

"Ammonia impairs neutrophil phagocytic function in liver disease" Hepatology (2008) 10.1002/hep.22474

[38]

"Prognostic role of ammonia in patients with cirrhosis" Hepatology (2019) 10.1002/hep.30534

[39]

"Muscle at risk: the multiple impacts of ammonia on sarcopenia and frailty in cirrhosis" Clin Transl Gastroenterol (2016)

[40]

"Hyperammonemia and proteostasis in cirrhosis" Curr Opin Clin Nutr Metab Care (2018)

[41]

"Hyperammonaemia‐induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress" J Physiol (2016) 10.1113/jp272796

[42]

"Continued muscle loss increases mortality in cirrhosis: impact of aetiology of liver disease" Liver Int (2020) 10.1111/liv.14358

[43]

"Skeletal muscle loss phenotype in cirrhosis: a nationwide analysis of hospitalized patients" Clin Nutr (2020) 10.1016/j.clnu.2020.03.032

[44]

"Muscle mass predicts outcomes following liver transplantation" Liver Transpl (2013) 10.1002/lt.23724

[45]

"Alcohol‐induced autophagy contributes to loss in skeletal muscle mass" Autophagy (2014) 10.4161/auto.27918

[46]

"Chronic ethanol feeding affects proteasome‐interacting proteins" Proteomics (2009) 10.1002/pmic.200800959

[47]

"IGF‐I/IGFBP‐3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol‐fed rats" Am J Physiol Endocrinol Metab (2004) 10.1152/ajpendo.00554.2003

[48]

"Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis" Hepatology (2017) 10.1002/hep.29420

[49]

"Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor" J Cell Physiol (2021) 10.1002/jcp.29839

[50]

"Outcomes after hepatic encephalopathy in population‐based cohorts of patients with cirrhosis" Aliment Pharmacol Ther (2020) 10.1111/apt.15749

Showing 50 of 270 references

Cited By

570

Specific Nutrition Evaluation for Advanced Chronic Liver Disease: Validation through Psychometrics Analysis

Monalisa Reis Arruda, Carla de Magalhães Cunha · 2026

Nutrition

Sarcopenia Risk Identified by Strength, Assistance With Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC-F) in Patients With Cirrhosis: A Real-World Cross-Sectional Study

Noor Albusta, Ali Yusuf · 2026

Cureus

Preventing First and Further Decompensation in Advanced Chronic Liver Disease

Leonardo Corrêa Süffert, Bernardo de Faria Moraes · 2026

Liver International

The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus

Avik Majumdar, Jacinta Holmes · 2026

Hepatology Communications

Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia

Marina Ribas Losasso, Maria Luiza Cesto Parussolo · 2025

International Journal of Molecular...

Liver diseases: epidemiology, causes, trends and predictions

Can Gan, Yuan Yuan · 2025

Signal Transduction and Targeted Th...

Increased Mortality Among Lean Versus Non‐Lean Adults With MASLD: A Multicenter Study

Leith Ghani, Majd B. Aboona · 2025

Journal of Gastroenterology and Hep...

Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma

Shu-xian Li, Wei Huang · 2025

World Journal of Surgical Oncology

Liver‐Secreted Extracellular Vesicles Promote Cirrhosis‐Associated Skeletal Muscle Injury Through mtDNA‐cGAS/STING Axis

Xiaoli Fan, Yunke Peng · 2025

Advanced Science

AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation

Lorna Dove, Ryan M. Chadha · 2025

Hepatology

Different modifiable risk factors for the development of non-advanced adenoma, advanced adenomatous lesion, and sessile serrated lesions, on screening colonoscopy

A. Reum Choe, Eun Mi Song · 2024

Scientific Reports

Prevalence and clinical impact of sarcopenia in liver transplant recipients: A meta-analysis

Min-Jie Jiang, Mu-Chen Wu · 2024

World Journal of Gastroenterology

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

· 2024

Obesity Facts

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Frank Tacke, Paul Horn · 2024

Journal of Hepatology

Akkermansia muciniphila is associated with normal muscle mass and Eggerthella is related with sarcopenia in cirrhosis

Irina Efremova, Aliya Alieva · 2024

Frontiers in Nutrition

Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference

Joerg M Pollok, Pascale Tinguely · 2023

The Lancet Gastroenterology & H...

Diagnosis and Management of Cirrhosis and Its Complications

Elliot B. Tapper, Neehar D. Parikh · 2023

JAMA

Lifestyle interventions in nonalcoholic fatty liver disease

Zobair M. Younossi, Shira Zelber-Sagi · 2023

Nature Reviews Gastroenterology &am...

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander-Tetri · 2023

Hepatology

Diagnosis and Pathogenesis of Sarcopenia in Chronic Liver Disease Using Liver Magnetic Resonance Imaging

Atsushi Nakamura, Tsubasa Yoshimura · 2022

Cureus

Metrics

570

Citations

270

References

Details

Published: Sep 01, 2021
Vol/Issue: 74(3)
Pages: 1611-1644
License: View

Authors

J

Jennifer C. Lai

Department of Medicine,University of California, San Francisco,San Francisco,CA

P

Puneeta Tandon

Division of Gastroenterology (Liver Unit),University of Alberta,Edmonton,Albert,Canada

W

William Bernal

Liver Intensive Therapy Unit, Institute of Liver Studies,Kings College Hospital,London,UK

E

Elliot B. Tapper

Division of Gastroenterology,University of Michigan,Ann Arbor,MI

U

Udeme Ekong

Georgetown University School of Medicine,Medstar Georgetown Transplant Institute,Washington,DC

S

Srinivasan Dasarathy

Department of Gastroenterology and Hepatology, Inflammation and Immunity,Lerner Research Institute, Cleveland Lerner Research Institute, Cleveland Clinic,Cleveland,OH

E

Elizabeth J. Carey

Division of Gastroenterology and Hepatology,Mayo Clinic in Arizona,Phoenix,AZ

Cite This Article

Jennifer C. Lai, Puneeta Tandon, William Bernal, et al. (2021). Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 74(3), 1611-1644. https://doi.org/10.1002/hep.32049

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

You May Also Like